$37.75
3.92% yesterday
NYSE, Jun 12, 10:10 pm CET
ISIN
US62548M1009
Symbol
CTEV

Claritev Stock price

$37.75
+15.94 73.09% 1M
+30.10 393.46% 6M
+22.97 155.41% YTD
+18.96 100.93% 1Y
-366.25 90.66% 5Y
-351.05 90.29% 10Y
-351.05 90.29% 20Y
NYSE, Closing price Thu, Jun 12 2025
-1.54 3.92%
ISIN
US62548M1009
Symbol
CTEV
Sector

Key metrics

Market capitalization $620.47m
Enterprise Value $5.21b
P/E (TTM) P/E ratio negative
EV/FCF (TTM) EV/FCF negative
EV/Sales (TTM) EV/Sales 5.62
P/S ratio (TTM) P/S ratio 0.67
P/B ratio (TTM) P/B ratio 41.85
Revenue growth (TTM) Revenue growth -3.33%
Revenue (TTM) Revenue $927.45m
EBIT (operating result TTM) EBIT $76.06m
Free Cash Flow (TTM) Free Cash Flow $-98.60m
Cash position $23.13m
EPS (TTM) EPS $-72.35
P/S forward 0.67
EV/Sales forward 5.64
Short interest 4.72%
Show more

Is Claritev a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,845 stocks worldwide.

Claritev Stock Analysis

Unlock Scores for Free

Analyst Opinions

3 Analysts have issued a Claritev forecast:

2x Buy
67%
1x Hold
33%

Analyst Opinions

3 Analysts have issued a Claritev forecast:

Buy
67%
Hold
33%

Financial data from Claritev

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Mar '25
+/-
%
927 927
3% 3%
100%
- Direct Costs 240 240
0% 0%
26%
688 688
4% 4%
74%
- Selling and Administrative Expenses 176 176
25% 25%
19%
- Research and Development Expense - -
-
-
512 512
12% 12%
55%
- Depreciation and Amortization 436 436
3% 3%
47%
EBIT (Operating Income) EBIT 76 76
51% 51%
8%
Net Profit -1,177 -1,177
86% 86%
-127%

In millions USD.

Don't miss a Thing! We will send you all news about Claritev directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Claritev Stock News

Neutral
Business Wire
16 days ago
MCLEAN, Va. & ABU DHABI, United Arab Emirates--(BUSINESS WIRE)---- $CTEV #CTEV--Claritev Corporation (“Claritev”) (NYSE: CTEV), a technology, data and insights company focused on making healthcare more affordable, transparent and fair for all, today announced it is deepening its investment in the Middle East North Africa (“MENA”) region and the market outside the United States with the appointm...
Neutral
Business Wire
3 months ago
SAN DIEGO--(BUSINESS WIRE)-- #5hmC--ClearNote Health's Avantect Pancreatic Cancer Test will now be available to members accessing Claritev's national PHCS and MultiPlan Networks.
Neutral
Seeking Alpha
4 months ago
Claritev Corporation (MPLN) Q4 2024 Earnings Call Transcript
More Claritev News

Company Profile

MultiPlan Corp. provides healthcare cost management solutions. It uses technology-enabled provider network, negotiation, claim pricing and payment accuracy services as building blocks for medical and dental payors to customize the healthcare cost management programs. The company was founded in 1980 and is headquartered in New York, NY.

Head office United States
CEO Travis Dalton
Founded 1980
Website www.claritev.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today